BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2457315)

  • 1. Comparative studies of inosine pranobex and acyclovir.
    Mindel A
    Am J Med; 1988 Aug; 85(2A):7-9. PubMed ID: 2457315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of first-attack genital herpes--acyclovir versus inosine pranobex.
    Mindel A; Kinghorn G; Allason-Jones E; Woolley P; Barton I; Faherty A; Jeavons M; Williams P; Patou G
    Lancet; 1987 May; 1(8543):1171-3. PubMed ID: 2437417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.
    Mindel A; Carney O; Sonnex C; Freris M; Patou G; Williams P
    Genitourin Med; 1989 Apr; 65(2):103-5. PubMed ID: 2473952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter randomized study of inosine pranobex versus acyclovir in the treatment of recurrent herpes labialis and recurrent herpes genitalis in Chinese patients.
    You Y; Wang L; Li Y; Wang Q; Cao S; Tu Y; Li S; Bai L; Lu J; Wei Z; Chen W; Hao F
    J Dermatol; 2015 Jun; 42(6):596-601. PubMed ID: 25819042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes.
    Mattison HR; Reichman RC; Benedetti J; Bolgiano D; Davis LG; Bailey-Farchione A; Remington M; Winter C; Corey L
    Am J Med; 1988 Aug; 85(2A):20-5. PubMed ID: 3044086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.
    Mertz GJ; Eron L; Kaufman R; Goldberg L; Raab B; Conant M; Mills J; Kurtz T; Davis LG
    Am J Med; 1988 Aug; 85(2A):14-9. PubMed ID: 3044076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-day regimen of valacyclovir for treatment of recurrent genital herpes simplex virus 2 infection.
    Bavaro JB; Drolette L; Koelle DM; Almekinder J; Warren T; Tyring S; Wald A
    Sex Transm Dis; 2008 Apr; 35(4):383-6. PubMed ID: 18362859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genital herpes: oral treatment with acyclovir.
    Ruhnek-Forsbeck M
    Scand J Infect Dis Suppl; 1985; 47():63-6. PubMed ID: 3912973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of genital warts with inosine pranobex (Imunovir): preliminary study.
    Mohanty KC; Scott CS
    Genitourin Med; 1986 Oct; 62(5):352-5. PubMed ID: 2429908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-day regimen of acyclovir for treatment of recurrent genital herpes simplex virus type 2 infection.
    Wald A; Carrell D; Remington M; Kexel E; Zeh J; Corey L
    Clin Infect Dis; 2002 Apr; 34(7):944-8. PubMed ID: 11880960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of recurrent genital herpes by single daily dosages of acyclovir.
    Mostow SR; Mayfield JL; Marr JJ; Drucker JL
    Am J Med; 1988 Aug; 85(2A):30-3. PubMed ID: 3044089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valacyclovir. New indication: for genital herpes, simpler administration.
    Can Fam Physician; 1999 Jul; 45():1698-700, 1703-5. PubMed ID: 10424269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year suppression of frequent recurrences of genital herpes with oral acyclovir.
    Baker DA; Blythe JG; Kaufman R; Hale R; Portnoy J
    Obstet Gynecol; 1989 Jan; 73(1):84-7. PubMed ID: 2642329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acyclovir vs isoprinosine (immunovir) for suppression of recurrent genital herpes simplex infection.
    Kinghorn GR; Woolley PD; Thin RN; De Maubeuge J; Foidart JM; Engst R
    Genitourin Med; 1992 Oct; 68(5):312-6. PubMed ID: 1385295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inosine pranobex for mucocutaneous herpes.
    Mindel A
    Lancet; 1985 Mar; 1(8429):631-2. PubMed ID: 2579303
    [No Abstract]   [Full Text] [Related]  

  • 16. Inosine pranobex and mucocutaneous herpes.
    Lancet; 1985 Jan; 1(8422):200-1. PubMed ID: 2578592
    [No Abstract]   [Full Text] [Related]  

  • 17. Inosine pranobex--only for use in controlled trials.
    Drug Ther Bull; 1986 Dec; 24(24):95-6. PubMed ID: 2433117
    [No Abstract]   [Full Text] [Related]  

  • 18. Valaciclovir: new indications. In genital herpes: simpler administration.
    Prescrire Int; 1999 Feb; 8(39):8-9. PubMed ID: 10557565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic experiences with the immunostimulator inosine pranobex].
    Darlath W; Wybran J
    Fortschr Med; 1984 Oct; 102(37):932-4. PubMed ID: 6209193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.